| Price | 6.75p on 04-06-2025 at 07:00:30 |
|---|---|
| Change | -0.15p -2.17% |
| Buy | 7.00p |
| Sell | 6.50p |
| Buy / Sell AGY Shares | |
| Last Trade: | Buy 5,000.00 at 6.95p |
| Day's Volume: | 5,000 |
| Last Close: | 6.90p |
| Open: | 6.95p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 6.75p - 6.95p |
| 52wk Range: | 3.88p - 7.85p |
| Market Capitalisation: | £322m |
| VWAP: | 6.95p |
| Shares in Issue: | 4,766m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 5,000 | 6.95p | Suspected BUY Trade |
08:00:27 - 04-Jun-25 |
| Buy* | 10,000 | 6.90p | Suspected BUY Trade |
16:35:25 - 03-Jun-25 |
| Buy* | 9,000 | 7.45p | Suspected BUY Trade |
14:00:22 - 03-Jun-25 |
| Sell* | 7,100 | 6.625p | Ordinary |
12:02:35 - 03-Jun-25 |
| Sell* | 1,904 | 6.625p | Ordinary |
10:02:45 - 03-Jun-25 |
| Buy* | 2,012 | 6.845p | Ordinary |
09:27:37 - 03-Jun-25 |
| Sell* | 45 | 6.50p | SI Trade |
08:00:11 - 03-Jun-25 |
| Buy* | 30,000 | 6.80p | Suspected BUY Trade |
16:35:13 - 02-Jun-25 |
| Sell* | 40,000 | 6.568p | Ordinary |
15:38:36 - 02-Jun-25 |
| Sell* | 3,000 | 6.568p | Ordinary |
15:18:42 - 02-Jun-25 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 31st Mar 2025 7:00 am | RNS | Interim Results for six months ended 31 Dec 2024 |
| 27th Mar 2025 7:00 am | RNS | Advancement to final phase of PROTECT trial |
| 3rd Mar 2025 7:00 am | RNS | New Executive Long Term Incentive Awards |
| 27th Feb 2025 7:00 am | RNS-R | Presentations at 2025 AAAAI / WAO Joint Congress |
| 17th Feb 2025 7:00 am | RNS | Grass MATA MPL Phase III data published in Allergy |
| 14th Feb 2025 7:00 am | RNS | Grant of Options |
| 28th Jan 2025 7:00 am | RNS | Half Year Trading update |
| 22nd Jan 2025 7:00 am | RNS | PDMR Dealing and Total Voting Rights |
| 15th Jan 2025 7:00 am | RNS | Director/PDMR Shareholding |
| 19th Dec 2024 1:41 pm | RNS | Exercise of Options and Total Voting Rights |
